Today news
About the same in other media
Pfizer raises Covid-19 vaccine sales forecast to $36bn for 2021
Reading now: 148
The US drugmaker Pfizer has lifted its 2021 forecast for revenues from its Covid vaccine to $36bn (£26.3bn), after bumper sales in the third quarter.
The Covid jab, called Comirnaty and developed with Germany’s BioNTech, contributed $13bn of revenues in the three months to 30 September. That was more than half of Pfizer’s total revenues of $24bn in the quarter, which rose 134% from a year earlier. In the first six months of the year, Corminaty revenues were $11.3bn.
Pfizer raised its 2021 forecast for Corminaty sales from $33.5bn in July, as it expects to deliver 2.3bn doses this year. Together with BioNTech, it continues to expect to manufacture 3bn doses by the end of December, although not all of them will be delivered by then.
Together
Read more on theguardian.comAbout this in other media
Car sales in Europe hit record low due to global microchip shortage euronews.com /3 years ago
Crypto.com Grabs Naming Rights of Staples Center for $700M blockchain.news /3 years ago
With Over USD 40M Raised, DAO is On the Cusp of Buying a Copy of US Constitution cryptonews.com /3 years ago
Show more
The website finance-news.co. is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
